Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abvc Biopharma (ABVC) Inventory (2018 - 2025)

Historic Inventory for Abvc Biopharma (ABVC) over the last 6 years, with Q3 2025 value amounting to $11460.0.

  • Abvc Biopharma's Inventory changed N/A to $11460.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $11460.0, marking a year-over-year change of. This contributed to the annual value of $25975.0 for FY2021, which is N/A changed from last year.
  • Per Abvc Biopharma's latest filing, its Inventory stood at $11460.0 for Q3 2025.
  • Over the past 5 years, Abvc Biopharma's Inventory peaked at $60007.0 during Q3 2021, and registered a low of $11460.0 during Q1 2025.
  • In the last 3 years, Abvc Biopharma's Inventory had a median value of $21172.0 in 2022 and averaged $23175.8.
  • Examining YoY changes over the last 5 years, Abvc Biopharma's Inventory showed a top increase of 6585.57% in 2022 and a maximum decrease of 6585.57% in 2022.
  • Over the past 3 years, Abvc Biopharma's Inventory (Quarter) stood at $25975.0 in 2021, then fell by 21.12% to $20489.0 in 2022, then crashed by 44.07% to $11460.0 in 2025.
  • Its Inventory was $11460.0 in Q3 2025, compared to $11460.0 in Q2 2025 and $11460.0 in Q1 2025.